Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 24, 2018

DrugPatentWatch Database Preview

Xanodyne Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for XANODYNE PHARM, and what generic and branded alternatives to XANODYNE PHARM drugs are available?

XANODYNE PHARM has nine approved drugs.

Summary for Xanodyne Pharm

US Patents:	0
Tradenames:	10
Ingredients:	7
NDAs:	9
Patent Litigation for Xanodyne Pharm:	See patent lawsuits for Xanodyne Pharm

Drugs and US Patents for Xanodyne Pharm

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Xanodyne Pharm	DARVOCET-N 100	acetaminophen; propoxyphene napsylate	TABLET;ORAL	017122-002	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Xanodyne Pharm	LEUCOVORIN CALCIUM	leucovorin calcium	TABLET;ORAL	071962-001	Nov 19, 1987		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Xanodyne Pharms Inc	ORAMORPH SR	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019977-003	Aug 15, 1991		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Xanodyne Pharms Inc	ORAMORPH SR	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019977-004	Nov 23, 1994		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi

Merck

Covington

Express Scripts

McKesson

Daiichi Sankyo

Queensland Health

Johnson and Johnson

Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.